A group of experts is calling for a fundamental rethink of how risk assessments are conducted, arguing that current frameworks fail to bridge the gap between scientific evidence, policy decisions and public trust.

The call, reported by ISAAA, centers on a familiar structural problem for R&D managers and regulators alike: assessments that are technically defensible can still lose legitimacy when the public does not understand or accept the assumptions behind them. The experts argue that closing that gap requires redesigning the assessment process itself, not just communicating results better after the fact.

For research organizations, the stakes are concrete. Risk assessments determine whether products clear regulatory hurdles, how long approval timelines run and how much evidence portfolio planning must budget for. A framework that policymakers and the public distrust can stall even well-supported science.

What is being proposed?

The experts' argument, as summarized by ISAAA, rests on three linked pillars:

• Science: grounding assessments in the best available evidence and transparent methods.
• Policy: ensuring regulatory decisions use that evidence in ways that are consistent and explainable.
• Public trust: involving stakeholders early enough that assumptions, uncertainties and value judgments are visible before decisions are finalized.

The emphasis on trust is not cosmetic. The experts' position implies that risk assessment cannot remain a purely technical exercise performed behind institutional walls. It must incorporate public concerns as an input, not treat them as a communications problem to be managed at the end.

Why does this matter for R&D planning?

The proposal touches directly on lab and portfolio workflows. If assessment frameworks shift toward earlier stakeholder engagement and greater transparency about uncertainty, R&D organizations would need to document methodological choices and data limitations more rigorously from the outset of a program.

That carries cost implications. Additional engagement processes and uncertainty analysis extend timelines and require staff time. The counterargument, implicit in the experts' push, is that late-stage public opposition or regulatory rejection costs far more than early transparency does.

The proposal also raises a question of accountability: who funds and conducts the assessments matters as much as what they find. Work underwritten by parties with a commercial stake in the outcome faces predictable skepticism, a point assessment redesign would need to address through governance rather than assertion.

What remains unresolved?

The ISAAA report outlines the direction, not a finished framework. Key operational questions stay open: which engagement mechanisms would count as meaningful public input, how conflicting stakeholder values should be weighed against quantitative evidence, and how revised processes would be validated across regulatory jurisdictions.

Absent implementation details and pilot results, the push remains a proposal. Its test will come when a regulator or research institution adopts the bridged approach and publishes outcomes against conventional assessment benchmarks — data the field currently lacks.

The experts' call signals that the next round of risk-assessment reform will be judged on trust as much as on technical merit, and organizations that build transparency into their evidence pipelines early will be positioned ahead of that shift.